Ticagrelor vs cilostazol for minor stroke or TIA
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two blood thinner medicines, ticagrelor and cilostazol, to see which is better at preventing another stroke in people who have just had a minor stroke or TIA (a mini-stroke). It is for people who started treatment within 24 hours of their symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had your first-ever minor stroke or TIA (transient ischemic attack, also called a mini-stroke) and started taking a blood thinner within 24 hours of symptoms starting.
- You are not eligible for a clot-busting medicine called rt-PA (a 'clot buster' given through an IV).
- You do not have severe bleeding risk, such as active stomach ulcers, recent major surgery, or a history of bleeding within the last year.
- You are not pregnant or breastfeeding, and do not have a known allergy to ticagrelor or cilostazol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
This trial compares two antiplatelet drugs (ticagrelor and cilostazol) to see which is better at preventing another stroke in people who have had a large-vessel ischemic stroke. Both drugs help keep blood clots from forming, and the study aims to find the safest and most effective option for patients who cannot receive clot-busting medication.
This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.